These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1510785

  • 21. Therapeutic use of thrombolytic agents.
    Stambaugh RL, Alexander MR.
    Am J Hosp Pharm; 1981 Jun; 38(6):817-24. PubMed ID: 7018230
    [Abstract] [Full Text] [Related]

  • 22. Thrombolytic therapy: current status (2).
    Marder VJ, Sherry S.
    N Engl J Med; 1988 Jun 16; 318(24):1585-95. PubMed ID: 3287158
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Thrombolytic therapy: overview of results in major vascular occlusions.
    Marder VJ.
    Thromb Haemost; 1995 Jul 16; 74(1):101-5. PubMed ID: 8578440
    [Abstract] [Full Text] [Related]

  • 28. [A different focus on the current status of thrombolysis in pulmonary thromboembolism].
    Jerjes Sánchez C, Ramírez Rivera A, Gutiérrez Fajardo P, García Castillo A, Cantú Díaz F, Treviño Ortiz H, Villarreal Garza I.
    Arch Inst Cardiol Mex; 1998 Jul 16; 68(2):166-80. PubMed ID: 9810361
    [No Abstract] [Full Text] [Related]

  • 29. Thrombolytic therapy.
    Brott T.
    Neurol Clin; 1992 Feb 16; 10(1):219-32. PubMed ID: 1557004
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. What should a new thrombolytic bring us?
    Verheugt F.
    Int J Clin Pract Suppl; 1998 Nov 16; 99():3-5. PubMed ID: 10344033
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Thrombolytic therapy in patients with submassive pulmonary embolism.
    Dalen JE.
    N Engl J Med; 2003 Jan 23; 348(4):357-9; author reply 357-9. PubMed ID: 12542064
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical trials with antithrombotic and thrombolytic agents. Principles and pitfalls.
    Sherry S.
    Thromb Diath Haemorrh; 1973 Feb 28; 29(1):3-10. PubMed ID: 4575327
    [No Abstract] [Full Text] [Related]

  • 38. [When is fibrinolytic therapy indicated?].
    Woitinas F.
    Med Klin; 1980 Feb 01; 75(3):98-107. PubMed ID: 6990218
    [No Abstract] [Full Text] [Related]

  • 39. Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.
    Fennerty AG, Levine MN, Hirsh J.
    Chest; 1989 Feb 01; 95(2 Suppl):88S-97S. PubMed ID: 2644106
    [No Abstract] [Full Text] [Related]

  • 40. [Indications for thrombolytics].
    Charbonnier B.
    Rev Prat; 1999 Oct 01; 49(15):1659-63. PubMed ID: 10581997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.